Retraction notices

Cost-utility analysis of trastuzumab combined with Docetaxel for patients with HER-2 positive metastatic breast cancer - real world claim data

Type

Retraction

Notice date

7/9/2018 0:00

Journal

Journal of Oncology Pharmacy Practice

Publisher

SAGE Publications

Notice DOI

10.1177/1078155218790179

Original paper DOI

10.1177/1078155218755548

Reasons

• Error in Data
• Unreliable Results and/or Conclusions

Matching venue names

Name match only, not an authoritative journal identifier.

• Journal of Oncology Pharmacy Practice